(Bloomberg) -- European stocks may advance for the
first time in six days on speculation shares have become cheap
relative to prospects for earnings growth.
Aviva Plc, HSBC Holdings Plc and UBS AG might lead financial
stocks higher after their U.S.-traded securities gained.
GlaxoSmithKline Plc, the region's second-largest drugmaker, may
rise after a panel of medical specialists said its Avandia drug
should remain on the U.S. market. BHP Billiton Ltd. and Rio Tinto
Group gained in Australia on higher copper prices.
Read more at Bloomberg Stocks News
first time in six days on speculation shares have become cheap
relative to prospects for earnings growth.
Aviva Plc, HSBC Holdings Plc and UBS AG might lead financial
stocks higher after their U.S.-traded securities gained.
GlaxoSmithKline Plc, the region's second-largest drugmaker, may
rise after a panel of medical specialists said its Avandia drug
should remain on the U.S. market. BHP Billiton Ltd. and Rio Tinto
Group gained in Australia on higher copper prices.
Read more at Bloomberg Stocks News